Bookmark Jamaica-Gleaner.com
Go-Jamaica Gleaner Classifieds Discover Jamaica Youth Link Jamaica
Business Directory Go Shopping inns of jamaica Local Communities

Home
Lead Stories
News
Business
Sport
Commentary
Letters
Entertainment
Let's Talk Life
A Pre-Mother's Day Shopping Feature
The Star
E-Financial Gleaner
Overseas News
The Voice
Communities
Hospitality Jamaica
Google
Web
Jamaica- gleaner.com

Archives
1998 - Now (HTML)
1834 - Now (PDF)
Services
Find a Jamaican
Library
Live Radio
Weather
Subscriptions
News by E-mail
Newsletter
Print Subscriptions
Interactive
Chat
Dating & Love
Free Email
Guestbook
ScreenSavers
Submit a Letter
WebCam
Weekly Poll
About Us
Advertising
Gleaner Company
Contact Us
Other News
Stabroek News

HIV vaccine trial by June
published: Saturday | May 13, 2006

Andrea Downer, Gleaner Writer


Figueroa

THE FIRST HIV vaccine trial in Jamaica is scheduled to begin next month.

Dr. Peter Figueroa, chief, epidemiology and AIDS in the Ministry of Health, made the disclosure yesterday during a press conference at the Comprehensive Health Centre in Kingston.

Approximately 480 volunteers from around the world, including 24 people from Jamaica, are expected to participate in the study.

Dr. Figueroa said it was not possible for persons to contract HIV or develop AIDS from the experimental vaccine.

"I must stress that it is not possible to get HIV infection or develop AIDS from experi-mental vaccines because they are not made from live HIV, killed HIV (or) weakened HIV or infected cells," he stated.

Dr. Figueroa explained that the vaccine to be used in the trial has been tested on mice, rabbits and monkeys as well as on human beings.

"The investigational vaccine was (also) tested in more than 250 people in a phase 1 trial. Two similar vaccines have been tested in more than 450 persons. Over the past several months, this experimental vaccine has been given to 180 volunteers in the United States," Dr. Figueroa revealed.

He said everything was done to ensure the safety of participants in those trials which were conducted under rigorous international standards and monitored closely by different regulatory agencies including the Food and Drug Administration in the United States.

Dr. Figueroa said persons who are HIV-positive are not eligible to participate in the study.

"Only persons who are HIV-negative and meet other criteria, will be eligible to participate," he stated. "The HIV vaccine will not prevent persons from contracting HIV and everyone who participates in the study will be counselled and encouraged to practise safe sex and avoid being exposed to the virus."

PREPAREDNESS STUDY

He said Jamaica has been conducting an HIV vaccine preparedness study over the past eight months. One hundred Jamaicans, 75 women and 25 men, are enrolled in that study, which should be completed in September this year. He added, however, that no experimental vaccine has been given to those persons.

Jamaica has been part of the worldwide HIV Vaccine Trials Network since April 2003. There are 27 testing sites worldwide and only three other Caribbean countries, Haiti, Puerto Rico and the Dominican Republic, are involved in the programme.

More Lead Stories



Print this Page

Letters to the Editor

Most Popular Stories





© Copyright 1997-2006 Gleaner Company Ltd.
Contact Us | Privacy Policy | Disclaimer | Letters to the Editor | Suggestions | Add our RSS feed
Home - Jamaica Gleaner